Caribou Biosciences Inc (CRBU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Sales | 3,303 | 4,192 | 2,664 | 2,559 | 3,977 |
| Gross Profit | 3,303 | 4,192 | 2,664 | 2,559 | 3,977 |
| Operating Expenses | 29,840 | 32,623 | 23,517 | 21,783 | 22,593 |
| Operating Income | -26,537 | -28,431 | -20,853 | -19,224 | -18,616 |
| Other Income | -110 | 1,734 | 1,765 | 1,066 | -2,358 |
| Pre-tax Income | -26,647 | -26,697 | -19,088 | -18,158 | -20,974 |
| Net Income Continuous | -26,647 | -26,697 | -19,088 | -18,479 | -20,974 |
| Net Income | $-26,647 | $-26,697 | $-19,088 | $-18,479 | $-20,974 |
| EPS Basic Total Ops | -0.44 | -0.44 | -0.32 | 1.13 | -0.46 |
| EPS Basic Continuous Ops | -0.44 | -0.44 | -0.32 | 1.12 | -0.46 |
| EPS Diluted Total Ops | -0.44 | -0.44 | -0.32 | 1.13 | -0.46 |
| EPS Diluted Continuous Ops | -0.44 | -0.44 | -0.32 | 1.12 | -0.46 |
| EBITDA(a) | $-26,430 | $-27,951 | $-20,218 | $-18,899 | $-18,356 |